Stryker Agrees to Purchase Artelon, Inc., Expanding Soft Tissue Fixation Solutions for Orthopaedic Surgeons

Tuesday, June 04, 2024

Stryker, a renowned player in medical technologies worldwide, has announced the signing of a definitive agreement to acquire all outstanding shares of Artelon.

Artelon, a privately held company specializing in cutting-edge soft tissue fixation products for foot and ankle and sports medicine procedures, will further solidify Stryker’s presence in the soft tissue fixation segment, underscoring its commitment to delivering innovative solutions for ligament and tendon reconstruction.

The acquisition of Artelon will broaden Stryker’s offerings in the foot and ankle and sports medicine fields, synergizing with its existing product range. With over 60,000 implantations globally.

Artelon’s synthetic technology is tailored to enhance both biological and mechanical aspects of ligament and tendon reconstruction.

This strategic move not only strengthens Stryker’s competitive position but also bolsters its foothold in these critical healthcare segments with advanced biomaterial technology aimed at supporting patients' soft tissue healing.

Confidence in the acquisition, emphasizing how Artelon’s established product portfolio and unique offerings will amplify Stryker’s capacity to innovate and meet customer needs.

The integration of Artelon’s products into Stryker’s already diverse foot and ankle and sports medicine portfolios aligns with their shared commitment to integrity, quality, and advancing healthcare provider knowledge for optimal clinical outcomes and patient rehabilitation.

Pending customary closing conditions, Stryker and Artelon will maintain separate operations, conducting business as usual until the transaction is finalized.


Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital Congress